Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics
about
Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentInsulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance.Design of Organic Macrocycle-Modified Iron Oxide Nanoparticles for Drug Delivery.Optical and Magnetic Resonance Imaging Using Fluorous Colloidal Nanoparticles.RCP induces FAK phosphorylation and ovarian cancer cell invasion with inhibition by curcumin.
P2860
Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics
@ast
Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics
@en
type
label
Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics
@ast
Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics
@en
prefLabel
Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics
@ast
Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics
@en
P2860
P1476
Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics
@en
P2093
Magnus Bergkvist
Sarah A Engelberth
P2860
P304
P356
10.1615/CRITREVONCOG.2014011455
P407
P577
2014-01-01T00:00:00Z